Prelude Therapeutics Incorporated
Status: Publicly traded
Direct answer
Prelude Therapeutics Incorporated is publicly traded on NASDAQ under the ticker PRLD.
Prelude Therapeutics, Inc. is a clinical-stage precision oncology company focused on identifying and developing innovative, targeted cancer treatments for patient populations with unmet medical needs. Its pipeline includes PRT543, currently undergoing Phase 1 clinical evaluation for certain solid tumors and myeloid malignancies. Another asset, PRT811, is also in Phase 1 trials, targeting various solid tumors,...
Can you invest in Prelude Therapeutics Incorporated?
Yes. Prelude Therapeutics Incorporated is publicly traded on NASDAQ under the ticker PRLD.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Prelude Therapeutics Incorporated
Detailed equity research is provided by MarketSnap.